Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

CompletedOBSERVATIONAL

Enrollment

7,200

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout

Interventions

DRUG

Risk of selected safety events

First time users of ticagrelor, clopidogrel and prasugrel, respectively

Trial Locations (1)

Research Site, Stockholm